Sign In
Buy MITO
$0.320
+0 (+0%)
At Close: Feb 14, 2023
NASDAQ market internals summary $NSD
03:17pm, Tuesday, 03'rd Mar 2020
NASDAQ market internals summary $NSD
NYSE market internals summary $NYE
03:16pm, Tuesday, 03'rd Mar 2020
NYSE market internals summary $NYE
The FOMC issued a statement in conjunction with its 50 bp rate cut
03:15pm, Tuesday, 03'rd Mar 2020
The FOMC issued a statement in conjunction with its 50 bp rate cut
Sempra Energy, Bechtel subsidiaries announce EPC agreement SRE
03:12pm, Tuesday, 03'rd Mar 2020
Sempra Energy, Bechtel subsidiaries announce EPC agreement SRE
Stealth Biotherapeutics jumps after drug granted RPD designation from FDA MITO
03:10pm, Tuesday, 03'rd Mar 2020
Stealth Biotherapeutics jumps after drug granted RPD designation from FDA MITO
Heavy call volume in low-dollar biotech Titan Pharmaceuticals TTNP
03:10pm, Tuesday, 03'rd Mar 2020
Heavy call volume in low-dollar biotech Titan Pharmaceuticals TTNP
Crinetics participates in a conference call with JPMorgan CRNX
03:09pm, Tuesday, 03'rd Mar 2020
Crinetics participates in a conference call with JPMorgan CRNX
Federal Reserve cuts federal funds rate by 1/2 percentage point SPY;SPX
03:01pm, Tuesday, 03'rd Mar 2020
Federal Reserve cuts federal funds rate by 1/2 percentage point SPY SPX
TSLA, INO among premarket gainers
02:22pm, Tuesday, 03'rd Mar 2020
Stealth BioTherapeutics (NASDAQ:MITO) +56% on Rare Pediatric Disease tag for elamipretide.GenMark Diagnostics (NASDAQ:GNMK) +28% as company ships ePlex RUO test kits for SARS-CoV-2 detection and Q4
Stealth Bio up 74% premarket on Rare Pediatric Disease tag for elamipretide
01:12pm, Tuesday, 03'rd Mar 2020
Thinly traded nano cap Stealth BioTherapeutics (NASDAQ:MITO) jumps 74% premarket on increased volume in reaction to its announcement that the FDA has granted Rare Pediatric Disease designation for e
40 Healthcare Stocks Moving In Tuesday's Pre-Market Session
01:10pm, Tuesday, 03'rd Mar 2020
Gainers
Stealth BioTherapeutics, Inc. (NASDAQ: MITO) shares surged 74.2% to $3.31 during Tuesday's pre-market session. According to the most recent rating by H.C....
FDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth Syndrome
12:30pm, Tuesday, 03'rd Mar 2020
Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfu
Stealth BioTherapeutics to Present at 40th Annual Cowen Health Care Conference
11:00pm, Thursday, 27'th Feb 2020
Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfu
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
01:28pm, Tuesday, 25'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainst
Zacks Investment Research Lowers Stealth BioTherapeutics (NASDAQ:MITO) to Hold
09:16am, Tuesday, 25'th Feb 2020
Stealth BioTherapeutics (NASDAQ:MITO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, �
